Short Interest in Recordati Industria Chimica e Farmaceutica S.p.A. (OTCMKTS:RCDTF) Increases By 60.1%

by · The Markets Daily

Recordati Industria Chimica e Farmaceutica S.p.A. (OTCMKTS:RCDTF – Get Free Report) saw a significant growth in short interest during the month of September. As of September 15th, there was short interest totalling 590,600 shares, a growth of 60.1% from the August 31st total of 369,000 shares. Based on an average daily volume of 100 shares, the short-interest ratio is currently 5,906.0 days.

Recordati Industria Chimica e Farmaceutica Price Performance

Shares of RCDTF stock remained flat at $52.25 during trading hours on Friday. The firm’s 50-day moving average is $52.13 and its two-hundred day moving average is $51.79. Recordati Industria Chimica e Farmaceutica has a fifty-two week low of $52.25 and a fifty-two week high of $52.25. The company has a current ratio of 1.36, a quick ratio of 0.95 and a debt-to-equity ratio of 0.73.

Recordati Industria Chimica e Farmaceutica (OTCMKTS:RCDTF – Get Free Report) last posted its quarterly earnings results on Tuesday, July 30th. The company reported $0.70 earnings per share (EPS) for the quarter. The business had revenue of $622.00 million for the quarter. Recordati Industria Chimica e Farmaceutica had a return on equity of 30.78% and a net margin of 17.41%.

About Recordati Industria Chimica e Farmaceutica

(Get Free Report)

Recordati Industria Chimica e Farmaceutica S.p.A., together with its subsidiaries, engages in the research, development, manufacture, and marketing of pharmaceuticals worldwide. The company operates through Specialty and Primary Care and Rare Diseases segments. Its product pipeline includes REC 0559 which is in Phase II for the treatment of Neurotrophic Keratitis; REC 0545 for acute decompensation in maple syrup urine diseases; ISTURISA for endogenous Cushing's syndrome; and CYSTADROPS, an corneal cystine deposits in patients with cystinosis.

Recommended Stories